Anzeige
Mehr »
Dienstag, 23.06.2026 - Börsentäglich über 12.000 News
Schuldenfrei, 1,5 Mio. Unzen Gold und Produktion ab 2027: Vor dem Ausbruch?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
581 Leser
Artikel bewerten:
(2)

Together Ever Launches Revionyx to Establish Longevity Infrastructure in Premium Pet Nutrition

The launch formally opens Together Ever's OEM and strategic partnership program. Brands and manufacturers can incorporate longevity positioning into current premium dog food, premium cat food, and supplement formulations without extensive reformulation or supply chain changes. Revionyx is structured as a branded ingredient platform that translates pet longevity science into scalable nutrition strategies.

Market Context and Category Evolution

The announcement comes amid sustained global expansion in the pet sector. According to Fortune Business Insights, the global pet care market was valued at $273 billion in 2025 and is projected to reach $496 billion by 2034. Pet food accounts for more than 52% of the market, underscoring nutrition as the primary economic driver in the broader pet industry.

Industry analyses across North America, Europe, and the Asia-Pacific region identify premiumization, functional pet nutrition, and humanization as key growth catalysts. As dogs and cats live longer due to advances in veterinary care and nutrition, category narratives are expanding toward healthy aging frameworks that extend across life stages.

"Companion animals are living longer than ever before, yet much of commercial pet nutrition still revolves around isolated functional claims," said Suoyi Feng, co-founder of Together Ever. "We believe longevity and healthy aging will define the next decade of premium pet nutrition. Revionyx was built to give brands a structured and scalable way to evolve with that shift."

A Modular Ingredient System for Healthy Aging

Revionyx is built around selected bioactive compounds associated with biological pathways studied in aging research, including mitochondrial support, cellular maintenance, and inflammatory balance. The system supports healthy aging for dogs and cats within a modular pet nutrition system framework.

The platform emphasizes ingredient-level branding in pet nutrition. Revionyx functions as an infrastructure layer that brands can incorporate into existing formulations. Brands can integrate the Revionyx system into premium dog and cat food and related supplement lines without initiating a full redevelopment cycle.

The Revionyx is designed to integrate into existing manufacturing and product development frameworks. The platform allows brands to introduce longevity positioning into established SKUs through a defined ingredient architecture.

As consumer demand evolves toward long-term vitality, manufacturers require scalable category strategies that extend beyond single-function positioning. Revionyx addresses this need through a modular ingredient system designed to expand across product portfolios.

OEM Program and Strategic Partnerships

With the formal launch, Together Ever has opened its OEM and strategic partnership program to qualified manufacturers and premium pet brands. The program is structured to support efficient integration into existing supply chains and formulation workflows.

Together Ever states that Revionyx is intended to help brands incorporate healthy aging positioning without significant research and development complexity. The company views longevity as an emerging axis of value creation within functional pet nutrition and broader premium category development.

About Together Ever

Together Ever is a pet longevity platform focused on translating advances in aging biology into scalable ingredient solutions for companion animals. Through its branded longevity system, Revionyx, the platform partners with premium pet brands seeking differentiated, future-oriented positioning in an increasingly competitive global market. Together Ever's strategy centers on ingredient-level branding, modular formulation systems, and long-term category development within premium pet nutrition.

Media Contact: Suoyi Feng

Email: suoyi@togetherever.com

Website: https://togetherever.com/

Photo - https://mma.prnewswire.com/media/2935342/Together_Ever.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/together-ever-launches-revionyx-to-establish-longevity-infrastructure-in-premium-pet-nutrition-302722599.html

© 2026 PR Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.